Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: Results from the BACH (Biomarkers in Acute Heart Failure) trial

A.M., research support from Roche, Biosite,\r\nand Bayer; consultant for Biosite. S.-X.N., consultant for ThermoFisher\r\nScientific. C.M., research grants from The Swiss National\r\nScience Foundation, the Swiss Heart Foundation, the Novartis\r\nFoundation, the Krokus Foundation, Abbott, Biosite, BRAHMS,\r\nRoche, and the University of Basel. R.M.N., research support\r\nfrom BRAHMS. W.F.P., Scientific Advisory Board of Abbott,\r\nBeckman-Coulter, Biosite, Inverness, Ortho Clinical Diagnostics,\r\nand Response Biomedical; research grants from Abbott, Biosite,\r\nand Inverness. M.R., Scientific Advisory Board of Inverness\r\nMedical; travel support, honoraria, and research grants from\r\nRoche Diagnostics and Inverness Medical (Biosite). G.S.F., research\r\nsupport from Biosite, BRAHMS, and Roche. S.D.S., consultant for\r\nBiosite. L.L.N., research support from BRAHMS, Inverness, and\r\nMedical Innovations. L.B.D., research grant from Roche. O.H.,\r\nemployee of BRAHMS GmbH. A.B. and N.G.M., former employees\r\nof BRAHMS GmbH. S.D.A., research support from BRAHMS; honoraria\r\nfrom Abbott and Biosite; consultant for BRAHMS.